Deals
Actavis Said to Compete With Sanofi for Omega Pharma Deal
This article is for subscribers only.
Actavis Plc is among the bidders for Omega Pharma NV, people with knowledge of the matter said, as the U.S. drugmaker continues hunting for acquisitions.
Actavis, a potential suitor as well as quarry in a dizzying number of potential pharmaceutical combinations in recent months, is competing with Perrigo Co., Sanofi and Boehringer Ingelheim GmbH for Omega Pharma, the people said, asking not to be identified because the information is private.